You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

Details for Patent: 11,235,168

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,235,168 protect, and when does it expire?

Patent 11,235,168 protects CYSVIEW KIT and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 11,235,168

Title:	Method of photodynamic therapy (PDT) for bladder cancer
Abstract:	This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.
Inventor(s):	Hestdal; Kjetil (Oslo, NO), Godal; Aslak (Oslo, NO)
Assignee:	PHOTOCURE ASA (Oslo, NO)
Application Number:	16/063,142
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 11,235,168

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				DETECTION OF CARCINOMA IN THE BLADDER BY PHOTODYNAMIC CYSTOSCOPY	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,235,168

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	15200938	Dec 17, 2015

PCT Information
PCT Filed	December 19, 2016	PCT Application Number:	PCT/EP2016/081809
PCT Publication Date:	June 22, 2017	PCT Publication Number:	WO2017/103285

International Family Members for US Patent 11,235,168

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016372575	⤷ Try a Trial
Brazil	112018011965	⤷ Try a Trial
Canada	3008552	⤷ Try a Trial
Chile	2018001612	⤷ Try a Trial
China	108697800	⤷ Try a Trial
Denmark	3389716	⤷ Try a Trial
European Patent Office	3389716	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.